2019 Scripps MD Anderson's Oncology Update


 

Scripps' 2019 ASCO Update on Advanced Urothelial Cancer: First-Line Bevacizumab, Maintenance Pembro Effect on PFS, New Data on the Use of Enfortumab Vedotin

August 30, 2019

0 Comments
Login to view comments. Click here to Login